The present invention relates to compounds of formula (I) having pharmacological activity towards the sigma (Ã) receptor, and more particularly to Pyrano-pyrazol-amine, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy and prophylaxis, in particular for the treatment of psychosis.